Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 17, 2025
January 16, 2025
21c15304-ad79-4fb0-8609-1712f3c9952b
Related Documents
Early Alzheimer’s Disease: Developing Drugs for Treatment
Guidance DocumentMarch 12, 2024Center for Drug Evaluation and Research
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment: Draft Guidance for Industry
Guidance DocumentAugust 17, 2020Office of the Commissioner
Setting Endotoxin Limits During Development of Investigational Oncology Drugs and Biological Products Guidance for Industry: Draft Guidance for Industry
Guidance DocumentJuly 28, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox